Found: 5
Select item for more details and to access through your institution.
Author Correction: Neuroprotective effects of ATPase inhibitory factor 1 preventing mitochondrial dysfunction in Parkinson's disease.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Neuroprotective effects of ATPase inhibitory factor 1 preventing mitochondrial dysfunction in Parkinson's disease.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07851-8
- By:
- Publication type:
- Article
Biglycan reduces body weight by regulating food intake in mice and improves glucose metabolism through AMPK/AKT dual pathways in skeletal muscle.
- Published in:
- FASEB Journal, 2021, v. 35, n. 8, p. 1, doi. 10.1096/fj.202002039RR
- By:
- Publication type:
- Article
Effect of chitinase‐3‐like protein 1 on glucose metabolism: In vitro skeletal muscle and human genetic association study.
- Published in:
- FASEB Journal, 2020, v. 34, n. 10, p. 13445, doi. 10.1096/fj.202000925R
- By:
- Publication type:
- Article
ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways.
- Published in:
- FASEB Journal, 2019, v. 33, n. 12, p. 14825, doi. 10.1096/fj.201901440RR
- By:
- Publication type:
- Article